A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trial

BACKGROUND: Peritoneal carcinomatosis is regarded as a common sign of advanced tumor stage, tumor progression or local recurrence of appendiceal and colorectal cancer and is generally associated with poor prognosis. Although survival of patients with advanced stage CRC has markedly improved over the...

Descripción completa

Detalles Bibliográficos
Autores principales: Glockzin, Gabriel, Rochon, Justine, Arnold, Dirk, Lang, Sven A, Klebl, Frank, Zeman, Florian, Koller, Michael, Schlitt, Hans J, Piso, Pompiliu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575316/
https://www.ncbi.nlm.nih.gov/pubmed/23391248
http://dx.doi.org/10.1186/1471-2407-13-67

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575316/
https://www.ncbi.nlm.nih.gov/pubmed/23391248
http://dx.doi.org/10.1186/1471-2407-13-67

Ejemplares similares